Seeking Alpha

Analytical Chemist

 
View as an RSS Feed
View Analytical Chemist's Articles BY TICKER:
  • Intel's Q1 Proves It Doesn't Need Mobile Chip Sales
    Apr. 19, 2011 INTC 13 Comments
  • Why I Sold Johnson & Johnson to Buy Abbott Labs
    Apr. 19, 2011 ABT, JNJ 42 Comments
  • A Look at Companies That Own U.S. Nuclear Power Plants
    Apr. 13, 2011 EXC, SO, CV 5 Comments
  • Meridian Bioscience: An Overvalued Dividend Contender
    Apr. 12, 2011 VIVO 8 Comments
  • DUSA: A Pharmaceutical With Profits Now and Strong Growth Ahead
    Apr. 11, 2011 DUSA 29 Comments
  • Pfizer Divestitures Part 3: Sale of Capsugel to KKR Is Positive
    Apr. 5, 2011 PFE, KKR, JNJ 2 Comments
  • Pfizer Divestitures Part 2: Who's Buying?
    Mar. 31, 2011 PFE, PRGO, ACT 5 Comments
  • Pfizer Divestitures Part 1: Greater Than the Sum of Its Parts
    Mar. 31, 2011 PFE 9 Comments
  • Companies Owning Nuclear Plants Could Present Opportunity
    Mar. 27, 2011 BRK.A, BRK.B, SO 19 Comments
  • The 5 Companies Most Dependent on Nuclear Power
    Mar. 25, 2011 EXC, CV, EE 10 Comments
  • Why Income Investors Should Consider Pfizer
    Mar. 22, 2011 PFE 13 Comments
  • Major Oil Companies' Exposure to Libya
    Mar. 19, 2011 XOM, RDS.A, RDS.B 24 Comments
  • How Eli Lilly Will Face Patent Expirations
    Mar. 14, 2011 LLY, PFE, JNJ 5 Comments
  • Why Dividend Investors Should Consider Eli Lilly
    Mar. 10, 2011 LLY 18 Comments
  • What's in a Berkshire Hathaway Share, Anyway?
    Mar. 6, 2011 BRK.A, BRK.B 10 Comments
  • Intel Report Card: A Classic Value Play
    Mar. 4, 2011 INTC 19 Comments
  • Pfizer: The Market's Undervalued Ugly Duckling
    Mar. 4, 2011 PFE 19 Comments